Clinical trials recruiting in Orchard Park, New York

Phase breakdown

Conditions recruiting in Orchard Park, New York

Recruiting trials in Orchard Park, New York

• PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
  NCT07611214 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
  NCT06711887 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Shield Post-Approval Study Protocol
  NCT06880055 · Phase: Not specified · Ages: 45 Years to 81 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Orchard Park, New York?

3 recruiting trials have at least one study site in Orchard Park, New York.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.